US 9029521
EML4-ALK fusion gene
granted A61KA61K31/506A61P
Quick answer
US patent 9029521 (EML4-ALK fusion gene) held by CUREGENE K.K. expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CUREGENE K.K.
- Grant date
- Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/506, A61P, A61P35/00, A61P43/00